MF59 Trademark

Trademark Overview

On Wednesday, December 18, 2013, a trademark application was filed for MF59 with the United States Patent and Trademark Office. The USPTO has given the MF59 trademark a serial number of 86147139. The federal status of this trademark filing is REGISTERED AND RENEWED as of Friday, December 12, 2025. This trademark is owned by Novartis AG. The MF59 trademark is filed in the Pharmaceutical Products category with the following description:

Adjuvants for vaccines
mf59

General Information

Serial Number86147139
Word MarkMF59
Filing DateWednesday, December 18, 2013
Status800 - REGISTERED AND RENEWED
Status DateFriday, December 12, 2025
Registration Number4575398
Registration DateTuesday, July 29, 2014
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 13, 2014

Trademark Statements

Pseudo MarkMF 59
Goods and ServicesAdjuvants for vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, January 4, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSEQIRUS UK LIMITED
Party Type31 - New Owner After Registration
Legal Entity Type99 - Other
AddressMAIDENHEAD, BERKSHIRE SL6 8AA
GB
Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBasel
CH
Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel
CH
Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel
CH

Trademark Events

Event DateEvent Description
Saturday, December 21, 2013NEW APPLICATION ENTERED
Saturday, January 4, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 7, 2014NOTICE OF PSEUDO MARK MAILED
Tuesday, March 25, 2014ASSIGNED TO EXAMINER
Wednesday, March 26, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, April 4, 2014ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Monday, April 7, 2014ELECTRONIC RECORD REVIEW COMPLETE
Wednesday, April 23, 2014NOTICE OF PUBLICATION
Tuesday, May 13, 2014PUBLISHED FOR OPPOSITION
Tuesday, July 29, 2014REGISTERED-PRINCIPAL REGISTER
Tuesday, January 31, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 5, 2017REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Wednesday, January 27, 2021TEAS SECTION 8 & 15 RECEIVED
Wednesday, February 10, 2021AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, May 26, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, May 26, 2021REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, May 26, 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Saturday, July 29, 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Tuesday, January 28, 2025TEAS VOLUNTARY AMENDMENT RECEIVED
Monday, January 27, 2025TEAS SECTION 8 & 9 RECEIVED
Friday, December 12, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, December 12, 2025REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Friday, December 12, 2025REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Friday, December 12, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

Related Keywords

vaccines adjuvants